ArticleCureus2026
Insomnia Symptoms in Doctor of Pharmacy Students in the United States: A Multicenter Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionInsomnia is a common sleep disorder that can negatively affect academic performance, mental health, and quality of life. Despite the rigor of Doctor of Pharmacy (PharmD) training, little is known about the prevalence of insomnia among PharmD students in the United States. This study evaluated the presence of insomnia across multiple institutions and characterized symptoms to inform targeted interventions. MATERIALS AND
methodsThis is a cross-sectional, institutional review board-exempt survey of pharmacy students at nine schools in the United States between March and April 2025. Participants completed demographic information and the Insomnia Symptom Questionnaire (ISQ), a validated 13-item instrument designed to detect insomnia. The primary outcome was the proportion of students meeting ISQ criteria for symptoms consistent with insomnia. Secondary outcomes included characterization of insomnia-related symptoms and comparisons by year in training. Descriptive statistics and chi-squared tests were applied.
resultsSeventy-three students completed the survey (mean age 25.5 years; 59% female; 74% Asian American). Overall, 26% met criteria for symptoms consistent with insomnia, with the highest prevalence among first-year (35%) and fourth-year (27.3%) students. Fatigue was the most common symptom, reported by 53.4% of students, followed by daytime sleepiness (38.3%) and concentration difficulties (37%). Difficulty staying asleep and frequent awakenings were less often endorsed.
conclusionsApproximately one in four PharmD students screened positive for symptoms consistent with insomnia, with fatigue and difficulty concentrating as prominent features. These findings highlight a potential need for wellness initiatives and targeted interventions to support sleep health in pharmacy education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.